-
Engineered immune cells deliver anticancer signal, prevent cancer from spreading
Wed, Mar 24 2021
In an NCI study, treating mice with engineered immune cells shrank tumors and prevented the cancer from spreading to other parts of the body. The immunotherapy approach shows promise as a potential treatment for metastatic cancer.
-
NCI statement on ending structural racism in biomedical research
Tue, Mar 02 2021
Statement from the National Cancer Institute in support of the NIH UNITE initiative to end structural racism in biomedical research. NCI Director Dr. Norman Sharpless describes NCI’s equity and inclusion efforts.
-
NCI study finds that people with SARS-CoV-2 antibodies may have a low risk of future infection
Wed, Feb 24 2021
A prior infection with SARS-CoV-2, the virus that causes COVID-19, appears to protect, at least for a few months, against reinfection from the virus, according to an NCI study. The finding may have important public health implications.
-
Fecal microbiota transplants help patients with advanced melanoma respond to immunotherapy
Thu, Feb 04 2021
For patients with cancers that do not respond to immunotherapy drugs, the use of fecal transplants to modify the gut microbiome may help some of these patients respond to the immunotherapy drugs.
